Last reviewed · How we verify

NCT04198337: EFTR

Endoscopic Full Thickness Resection for Gastric GIST

Status unknown NA Last updated 7 November 2023
What this trial tests

NA trial testing Endoscopic Full Thickness Resection in Gastric GIST in 30 participants. Status unknown.

Timeline
1 August 2014
Primary endpoint
31 December 2024
31 December 2024

Quick facts

Lead sponsorChinese University of Hong Kong
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment30
Start date1 August 2014
Primary completion31 December 2024
Estimated completion31 December 2024
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Chinese University of Hong Kong

Who can join

Adults 18 to 80, any sex, with Gastric GIST. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a clinical trial to evaluate the efficacy and safety of endoscopic full thickness resection for treatment of gastric GIST

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Chinese University of Hong Kong trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04198337.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing